158 related articles for article (PubMed ID: 35123755)
1. Chitosan derivatives functionalized dual ROS-responsive nanocarriers to enhance synergistic oxidation-chemotherapy.
Liao JX; Huang QF; Li YH; Zhang DW; Wang GH
Carbohydr Polym; 2022 Apr; 282():119087. PubMed ID: 35123755
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
Lee S; Lee SA; Shinn J; Lee Y
Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
[TBL] [Abstract][Full Text] [Related]
3. A pH/ROS-responsive, tumor-targeted drug delivery system based on carboxymethyl chitin gated hollow mesoporous silica nanoparticles for anti-tumor chemotherapy.
Ding X; Yu W; Wan Y; Yang M; Hua C; Peng N; Liu Y
Carbohydr Polym; 2020 Oct; 245():116493. PubMed ID: 32718608
[TBL] [Abstract][Full Text] [Related]
4. Self-sufficing H2O2-responsive nanocarriers through tumor-specific H2O2 production for synergistic oxidation-chemotherapy.
Li J; Ke W; Wang L; Huang M; Yin W; Zhang P; Chen Q; Ge Z
J Control Release; 2016 Mar; 225():64-74. PubMed ID: 26806789
[TBL] [Abstract][Full Text] [Related]
5. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance.
Zhong XC; Shi MH; Liu HN; Chen JJ; Wang TT; Lin MT; Zhang ZT; Zhou Y; Lu YY; Xu WH; Gao JQ; Xu DH; Han M; Chen YD
Pharm Dev Technol; 2021 Jan; 26(1):21-29. PubMed ID: 33070673
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species activated nanoparticles with tumor acidity internalization for precise anticancer therapy.
Deng H; Zhao X; Deng L; Liu J; Dong A
J Control Release; 2017 Jun; 255():142-153. PubMed ID: 28385677
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
9. Cargo-Free Nanomedicine with pH Sensitivity for Codelivery of DOX Conjugated Prodrug with SN38 To Synergistically Eradicate Breast Cancer Stem Cells.
Sun N; Zhao C; Cheng R; Liu Z; Li X; Lu A; Tian Z; Yang Z
Mol Pharm; 2018 Aug; 15(8):3343-3355. PubMed ID: 29923726
[TBL] [Abstract][Full Text] [Related]
10. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
[TBL] [Abstract][Full Text] [Related]
11. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
[TBL] [Abstract][Full Text] [Related]
12. Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy.
Yoo J; Sanoj Rejinold N; Lee D; Jon S; Kim YC
J Control Release; 2017 Oct; 264():89-101. PubMed ID: 28842316
[TBL] [Abstract][Full Text] [Related]
13. Chitosan oligosaccharide-functionalized nano-prodrug for cascade chemotherapy through oxidative stress amplification.
Cui L; Xu Q; Lou W; Wang Y; Xi X; Chen Y; Sun M; Wang Z; Zhang P; Yang S; Zhang L; Qu L
Int J Biol Macromol; 2024 May; 268(Pt 2):131641. PubMed ID: 38641277
[TBL] [Abstract][Full Text] [Related]
14. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
15. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y
Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900
[TBL] [Abstract][Full Text] [Related]
16. pH triggered re-assembly of nanosphere to nanofiber: The role of peptide conformational change for enhanced cancer therapy.
Liang P; Zheng J; Dai S; Wang J; Zhang Z; Kang T; Quan C
J Control Release; 2017 Aug; 260():22-31. PubMed ID: 28522193
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
18. Integrated block copolymer prodrug nanoparticles for combination of tumor oxidative stress amplification and ROS-responsive drug release.
Yin W; Ke W; Chen W; Xi L; Zhou Q; Mukerabigwi JF; Ge Z
Biomaterials; 2019 Mar; 195():63-74. PubMed ID: 30612064
[TBL] [Abstract][Full Text] [Related]
19. Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy.
Yin W; Ke W; Lu N; Wang Y; Japir AAMM; Mohammed F; Wang Y; Pan Y; Ge Z
Biomacromolecules; 2020 Feb; 21(2):921-929. PubMed ID: 31961134
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate-anthocyanin nanocomplex for efficient tumor therapy.
Jeong D; Bae BC; Park SJ; Na K
J Control Release; 2016 Jan; 222():78-85. PubMed ID: 26686664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
